redeemer
Bluelighter
- Joined
- Sep 14, 2003
- Messages
- 2,135
Combining the CYP3A4 inhibitor ketoconazole with methylated morphine derivatives
The enzyme CYP3A4 converts methylated morphine derivatives (oxycodone, hydrocodone, codeine) to a pharmacologically inactive substance. According to this study ketoconazole and troleandomycin inhibited the conversion of hydrocodone to the inactive norhydrocodone.
Would a combination of an appropriate dose of ketoconazole and hydrocodone, oxycodone or codeine be safe, ie. would the inhibition cause an overdose or just prolong the effects?
If so, what would the respective doses of the enzyme inhibitor and the opioid be?
The enzyme CYP3A4 converts methylated morphine derivatives (oxycodone, hydrocodone, codeine) to a pharmacologically inactive substance. According to this study ketoconazole and troleandomycin inhibited the conversion of hydrocodone to the inactive norhydrocodone.
Would a combination of an appropriate dose of ketoconazole and hydrocodone, oxycodone or codeine be safe, ie. would the inhibition cause an overdose or just prolong the effects?
If so, what would the respective doses of the enzyme inhibitor and the opioid be?
